World Congress Insulin Resistance and Cardiovascular Disease

 

World Congress Insulin Resistance and Cardiovascular Disease

CV Outcome Trials: Impact on Clinical Management of Dyslipidemia in CVD Prevention

By World Congress Insulin Resistance and Cardiovascular Disease
By World Congress Insulin Resistance and Cardiovascular Disease
0 views
March 14, 2018
Comments 0
Login to view comments. Click here to Login
2017 Annual Meeting
16:41
World Congress Insulin Resistance and Cardiovascular Disease

CV Outcome Trials: Impact on Clinical Management of Dyslipidemia in …

29:13
World Congress Insulin Resistance and Cardiovascular Disease

Lipotoxicity and NAFLD: The Overlooked Complication of T2DM

09:40
World Congress Insulin Resistance and Cardiovascular Disease

The AACE/ACE Guidelines for the Managment of Dyslipidemia and Preven…

24:15
World Congress Insulin Resistance and Cardiovascular Disease

Menopause, Estrogens and Lipoprotein Particles

18:55
World Congress Insulin Resistance and Cardiovascular Disease

Cellular Mechanisms for Lipid Induced Muscle Insulin Resistance